Werbung
Werbung
TRVI
Trevi Therapeutics, Inc. Common Stock
11.18
USDGesponsert
-0.03
-0.25%
09. Jan., 15:59 UTC -5
Geschlossen
Vor-Markt
11.27
+0.09
+0.81%
TRVI Ergebnisberichte
Positives Überraschungsverhältnis
TRVI übertreffen die 18 der letzten 26Schätzungen.
69%
Nächster Bericht
Datum des nächsten Berichts
16. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.10
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/+25.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-9.09%
Trevi Therapeutics, Inc. Common Stock earnings per share and revenue
On 13. Nov. 2025, TRVI reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.10 USD, resulting in a 20.24% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.79% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an increase of 25.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Trevi Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Trevi Therapeutics, Inc. Common Stock reported EPS of -$0.08, beating estimates by 20.24%, and revenue of $0.00, 0% as expectations.
How did the market react to Trevi Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -0.79%, changed from $11.46 before the earnings release to $11.37 the day after.
When is Trevi Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 16. März 2026.
What are the forecasts for Trevi Therapeutics, Inc. Common Stock's next earnings report?
Based on 14
analysts, Trevi Therapeutics, Inc. Common Stock is expected to report EPS of -$0.10 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung